Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Georg Manolikakes Carmela Matrone Matthias Piesche Michael Parnham Karsten T Flügel |
| Publication date | November 4, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |